Time of maximum cycloplegia after instillation of cyclopentolate 1% in children with brown irises

Sittikorn Laojaroenwanit1, Vimontip Layanun1, Pokpong Praneeprachachon1

  • 1Department of Ophthalmology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Insights

Maximum cycloplegia in children with brown irises occurs 30 minutes after the first cyclopentolate drop. Pupillary reaction is not a reliable indicator of maximum cycloplegia.

Area of Science:

  • Ophthalmology
  • Pediatric Eye Care
  • Pharmacology

Background:

  • Accurate refractive error assessment in children is crucial for timely intervention.
  • Cyclopentolate is a commonly used cycloplegic agent in pediatric eye examinations.
  • Understanding the onset of maximum cycloplegia is essential for optimizing examination protocols.

Purpose of the Study:

  • To determine the time to maximum cycloplegia after cyclopentolate 1% instillation in children with brown irises.
  • To assess the correlation between pupillary reaction and the time of maximum cycloplegia.
  • To identify any adverse effects associated with cyclopentolate use.

Main Methods:

  • Prospective analytical study of children aged 5-14 years undergoing refraction.
  • Cyclopentolate 1% instilled three times at 10-minute intervals.
  • Spherical equivalent, pupillary reaction, and diameter recorded pre-instillation and at nine intervals post-instillation.

Main Results:

  • Maximum cycloplegia was achieved at 30 minutes post-first instillation in most children.
  • A weak correlation (r=-0.07) was found between pupillary reaction and time to maximum cycloplegia.
  • No significant side effects were reported during the study period.

Conclusions:

  • The onset of maximum cycloplegia following cyclopentolate 1% in children with brown irises is approximately 30 minutes after the initial dose.
  • Pupillary response is an unreliable indicator for determining the peak effect of cyclopentolate.
  • Cyclopentolate 1% appears safe for use in this pediatric population.
Abstract

Related Concept Videos

Ophthalmic Drug Delivery Systems01:23

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
191
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
2.0K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K